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Abstract A transmission cluster of HIV-1 M:B was
identiﬁed in 11 patients with a median age of 52 (range 26–
65) in North-East Germany by C2V4 region sequencing of
the env gene of HIV-1, who—except of one—were not
aware of any risky behaviour. The 10 male and 1 female
patients deteriorated immunologically, according to their
information made available, within 4 years after a putative
HIV acquisition. Nucleic acid sequence analysis showed a
R5 virus in all patients and in 7 of 11 a crown motif of the
V3 loop, GPGSALFTT, which is found rarely. Analysis of
formation of this cluster showed that there is still a huge
discrepancy between awareness and behaviour regarding
HIV transmission in middle-aged patients, and that a local
outbreak can be detected by nucleic acid analysis of the
hypervariable env region.
Keywords HIV transmission   Epidemiology  
Cluster   Risky behaviour   Local outbreak  
Middle-aged people
Introduction
The route of sexual spread of human immunodeﬁciency
virus (HIV) is known since 1981 [1]. Awareness of spread
of this infectious agent in different parts and different
people of Germany is variable, with a trend that espe-
cially young homosexual men (MSM) are predominantly
affected [2].
The aim of this study was to ﬁnd the route of trans-
mission of HIV infection in a few patients who presented
with AIDS or AIDS-like symptoms in a group of middle-
aged people non-exposed to obvious epidemiological or
individual risk factors.
Patients
All patients, 10 males and 1 female, were born and/or
living in a geographically restricted area around Greifs-
wald. Patients’ data are summarized in Table 1. Patients
had been identiﬁed and analysed as HIV infected either
according to their clinical AIDS-deﬁning symptoms or
after getting information that a sexual partner was found to
be HIV infected. One of the patients was identiﬁed when he
desired to donate blood.
Most patients could not explain how, when and where
they acquired their HIV infection. Only one of the male
patients named his HIV-infected source partner; he stated
to be HIV antibody negative before his homosexual rela-
tionship started with the index patient. This index patient
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nucleic acid sequence analysis. Additionally, a person who
might be the real source of spread of this HIV infection
could not be traced, despite several efforts made.
Materials and methods
For nucleic acid sequence analysis, EDTA blood was
drawn by venepuncture. HIV antibody was tested from the
EDTA-plasma with a commercially available kit (Enzy-
gnost, Dade-Behring, Marburg, Germany). Presence of
antibody was conﬁrmed by immunoblot (HIV-Innolia,
Innogenetics, Ghent, Belgium). Viral load was determined
by the Amplicor Monitor test (Roche, Alameda, CA, USA;
no longer available). CD4 cells were measured by FACS
analysis (Becton–Dickinson, Heidelberg, Germany).
RNA was extracted from EDTA-plasma according to
the recommendation of the manufacturer (Qiagen, Hilden,
Germany). RNA was transcribed to DNA by reverse tran-
scription using a one step RT-PCR (Superscript, Invitro-
gen, Carlsbad, CA) at 50C for 30 min, followed by a
nested PCR using Taq polymerase (Platinum Taq poly-
merase, Invitrogen, Carlsbad, CA). PCR-cycling conditions
were denaturation at 92C for 30 s, annealing at 50C for
90 s, and elongation at 72C for 90 s, cycling 30 times.
Final elongation was done at 72C for 7 min.
Primers used were (in 50 to 30 direction)
5env 6901: CCT CAg CCA TTA CAC Agg CCT gTC
CAA Ag (HXB2 6818-6846) and 3env 7681: ATA TAA
TTC ACT TCT CCA ATT gTC (HXB2 7792-7616) for the
ﬁrst ampliﬁcation step; and 5env 7001: gCA CAg TAC
AAT gTA CAC ATg gAA (HXB2 6949-6974) and
3env7401: TTA CAg TAg AAA AAT TCT CCT C (HXB2
7380-7361) for the second ampliﬁcation step.
Ampliﬁcates of the second/nested PCR were analysed
by 2.5% agarose gel electrophoresis in the presence of
ethidium bromide, and the speciﬁc band was after
puriﬁcation subjected to the dideoxynucleotide sequenc-
ing cycles [3] using the AbiPrism labelling kit and
the 301 sequence analyser (Applied Biosystems, Weit-
erstadt, Germany). Sequences were analysed and aligned
with the Sequence Navigator or BioEdit (http://www.
mbio.ncsu.edu/BioEdit) program. Construction of the
phylogenetic tree was performed using 372 nucleotides
of the C2V4 region including the V3 loop by the
Treecon and Mega 4 program [4, 5]. Pathogenicity
index and X4/R5-coreceptor use was calculated accord-
ing to the formula of Briggs et al. [6] weighing the
charge of acidic and basic amino acid residues in the V3
loop.
Mutation rate was calculated using an average rate of
0.5% per year in the V3 loop published 1990 by Balfe
et al. [7] for recently infected haemophiliacs, which is
close to the data given by Ji and Loeb [8] of 2 in 10
4
errors per base per replication cycle in the V1 gene and of
Salazar-Gonzales et al. [9] of 1.7 9 10
-5 substitution per
site per day in the whole env gene in asymptomatic
individuals, which is 0.6% per year. The average transi-
tion/transversion rate within the env/V3 was given with
1.42 [10], which is higher than in other parts of the env
gene.
Table 1 Demographic data, laboratory test results, and clinical parameters obtained from the patients included in this study
Patient
number
Sex Age at
diagnosis
Viral load (cop/ml)
at the ﬁrst hospital visit
CD4 cells/lla t
diagnosis
Coreceptor
tropism R5/X4
V3 loop crown
motif
Disease
stage
Main
symptoms
HGW1 M 61 48,000 550 R5 GPGRALYST C1 Atrophic dermatitis
HGW2 M 48 310,000 270 R5 GPGSALFTT C3 Weight loss
Neurologic
HGW3 M 46 125,000 150 R5 GPGRALFTT C3 Neurologic
HGW4 M 57 72,000 120 R5 RPGSALFTT
a
GPGSALFTT
C3 Marasmus
Zoster
HGW5 F 55 41,000 250 R5 GPGSALFTT A2 None
HGW6 M 56 87,000 330 R5 GPGSALFTT C3 Weight loss
Pemphigus
HGW7 M 26 330,000 170 R5 GPGRALYTT C3 Weight loss
HGW8 M 39 29,000 600 R5 GPGRALLTT C2 Candidiasis
HGW9 M 65 11,000 650 R5 GPGSALFTT A1 None
HGW10 M 64 32,000 540 R5 GPGSALFTT C2 None
HGW11 M 52 280,000 45 R5 GPGSALFTT C3 Weight loss
Candidiasis
a Both sequences were found in this patient, circulating in approximately equal amounts
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Patients
In comparison to other epidemiological studies that
reported a clustering of HIV transmission, the high age of
the majority of the patients, in average 52, range 26–65,
is remarkable; additionally, it is striking that only
one female was involved, who was most probably
infected by her husband. Nine of the 11 patients showed a
clinical presentation compatible with advanced signs of
immunodeﬁciency.
Analysis of the nucleic acid sequence of the C2V4
region
The crown motif of the viruses could be ranked in two
groups, GPGSALFTT, which was found in seven
patients—in patient HGW4 an nearly equal mixture of the
N terminal G and R was found—and GPGRALYST/
GPGRALYTT in the remaining four patients (Table 1).
The codon AGT for the amino acid S (serine) was con-
served in all sequences while a codon AGG (twice) and
AGA (once) was used for R (arginine) in the GPGS or
GPGR crown motif, indicating that an exchange of G or A
by T in the third position was the drive for selection of
serine. The codon of the aspartic acid (D) in amino acid
position 321, within the C-terminal part of the V3 loop,
was deleted in all sequenced strains of these patients (see
below for three sequences and in Table 2), which is a rare
event. However, it was found initially in the LAI/BRU
virus (clone HXB2), as shown below (the one letter code of
amino acids was used).
amino acid position/
Mutation rate and duration of HIV infection
Analysis of the nucleic acid sequences of the couple
HGW4 and HGW5 revealed 80 mutations per 340 nucle-
otides in the C2V4 region. Considering a mutation rate in 2
individuals and an increase of mutations in the HGW4
patient with severe symptoms of AIDS of 1% per year [11],
the time point of infection could have been 12 years
ahead—around 1994. In contrast, the information given by
the male patient on his putative infection time was 2002.
Another, homosexually active, patient of this cluster
focused his time point of infection around 7 years ago,
which is more close to the 12 years time point of diver-
gence of the cluster of these patients.
Phylogenetic tree
Compared to the more than 100 HIV-1 subtype B strains
analysed in our laboratories, all C2V4 sequences of the
11 patients clustered together and were thus epidemio-
logically linked (Fig. 1). Boot strap analysis revealed a
value 57–86 of 100 for the branching of this cluster from
all other subtype B sequences, running 1,000 compari-
sons. There was no difference between the tree con-
structed by the Treecon program or the Mega4 program,
in both trees the cluster of the 11 sequences segregated
separately from all other HIV-1 M B-subtypes. Within
the 177 nucleic acid sequences of the C2V4 region
analysed, and within all sequences available at the Los
Alamos Data Base (update 2007), there was no other
nucleic acid sequence identical to that of the majority of
this cluster.
Discussion
This study describes a further cluster of HIV transmission
to 11 patients in a locally restricted area identiﬁed by
nucleic acid sequencing of part of the env gene region. By
the same method, an intrafamiliar cluster of HIV-1 trans-
mission involving three persons had been identiﬁed in
France in 1998 [12], as well as heterosexual transmission
of HIV-1 in Senegal [13] and in Belgium by a man origi-
nating from Rwanda who infected from 1992 to 1996 six
recipients [14]. By nucleic acid sequence analysis of the
pol gene, not the env gene, the transmission of multiple
drug-resistant HIV in a cluster was determined [15]. Earlier
reports describe the transmission of HIV-1 to 11 middle-
aged women by one man in Belgium 1989 [16], from one
man to 13 women in 2002 in New York [17]. Genotypic
signature characteristics with a lower charge of the V3 loop
in the recipients had been described in a study in Uganda
[18], this charge difference was not found in the cluster
described here. Regional HIV outbreaks have been repor-
ted more recently in Quebec [19] especially during the
acute/early period of HIV infection identifying at least 7
(range 2–17) transmission clusters involving 293 people
with a medium age between 34 and 39 ± 10. Another
study involved approximately 65 persons of whom at least
three were infected heterosexually during a short period in
Los Angeles in 2004 in the adult ﬁlm industry where the
index patient had an age of 40 [20].
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patients form a unique cluster, with V3 loop sequences that
had not been described previously (see Fig. 1); since the
V3 loop is hypervariable the C2V4 region was selected to
get valuable information. For the cluster analysis the
choice of the HIV gene region is more important than the
program used [21]. Further statistical methods, as maxi-
mum-likelihood or Bayesian approach, cannot support
Table 2 C2V4 amino acid sequences of the patients involved in the cluster, aligned to the HXB2 sequence
The one letter code of amino acid sequences was used. In the middle, the GPGR motif of the crown of the V3 loop may be seen. The sequences
start at the amino acid position 258 of HXB2 according to the sequence counting of Los Alamos data base (21)
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Fig. 1 Phylogenetic tree of the
nucleic acid sequences of 177
HIV’s, including some
reference sequences for
comparative analysis of the
HIV-1 group B sequences of the
patients of the described cluster,
drawn with the Mega 4
program. As may be seen in the
lower part of the tree, marked
with the red square, the cluster
is formed by the 11 sequences
(HGW1–11) and separated from
all other sequences analysed in
Greifswald (FLI), Mu ¨nchen
(MVP) and Frankfurt (FFM).
Roughly the position of subtype
B strains (bow on the right), and
of subtypes A, A/E and F
(dashed lines) are given; the
position of the 3 group O strains
is indicated with a double line
on the left upper end of the tree
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123relationship of various HIV when there is a strong virologic
link [22]—as described here.
The crown motif of the V3 loop with the amino acid
sequence GPGSALFTT, which was found in 7 of the 11
patients, has not been deposed in the Los Alamos Data Bank
(http://www.hiv.lanl.gov/)[ 23]. Beneath 1,766 sequences
available there were 4 similar subtype B sequences with the
crown motif GPGSALxxx or xxGSALFxx one from Spain
(B.ES.xLPM.MHO2.EF531331), one from Ecuador
(B.EC.89.EC102.AY173960), and two from United States,
indicating how rare this sequence motif is.
Analysis of the therapy naı ¨ve patients of this cluster
yielded the following peculiarities: a median age of
approximately 52, which is high compared to other studies
[18, 20]. According to the information given by the
patients, unawareness of any risky behaviour in the past or
inability to realize where and when risky behaviour had
happened, as has been reported in previous studies as well
[16, 24]. All patients were carrying a R5 virus, despite the
manifestation of full blown AIDS in 5 patients (see
Table 1), and all viruses of this cluster had no mutations in
the pol-gene linked to drug resistance of the protease and
reverse transcriptase (data not shown).
Regarding this cluster, it is striking that only one female
was involved, who was most probably infected by her hus-
band. Additionally, 8 of the 11 patients were married.
Despite the various efforts made the source—one or several
index patients [19, 25, 26]—and the route of HIV-1 trans-
mission—homosexual, bisexual, heterosexual—in this
cluster is still unclear. To get access to the source of infec-
tion,afurtherdescribedwayforclusteranalysisisbypartner
notiﬁcation, without nucleic acid sequencing [25, 27, 28],
which was not possible for these 11 patients investigated.
The HIV infection of these patients opens a considerable
gap of knowledge concerning HIV transmission in a non-
promiscuitive setting, since only one of the patients was
willing or able to give information on his route of infection.
Most of the patients involved were identiﬁed by deterio-
ration of the immune system between 2005 and 2008. Low
awareness of the risk of HIV transmission is a fundamental
cofactor in the spread of HIV within communities. There
had been several, annually repeated efforts to rise the level
of awareness focused on the social status, on ethnic
minorities, on sexual preference, on education, and on
prevention modes [16, 23, 24, 28, 29]. This low awareness
is not country dependent, mostly independent of funding,
but highly dependent on human behaviour [26, 30]. The
cluster described in this paper shows that besides young
people and predominantly young MSM in the western
world also elderly people are at risk of HIV acquisition and
unaware of their risky behaviour even after 25 years of
HIV counselling and information [31] and that information
campaigns should address all age groups.
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